<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>332(8)</volume><submitter>Abdul-Aziz MH</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>There is uncertainty about whether prolonged infusions of β-lactam antibiotics improve clinically important outcomes in critically ill adults with sepsis or septic shock.&lt;h4>Objective&lt;/h4>To determine whether prolonged β-lactam antibiotic infusions are associated with a reduced risk of death in critically ill adults with sepsis or septic shock compared with intermittent infusions.&lt;h4>Data sources&lt;/h4>The primary search was conducted with MEDLINE (via PubMed), CINAHL, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov from inception to May 2, 2024.&lt;h4>Study selection&lt;/h4>Randomized clinical trials comparing prolonged (continuous or extended) and intermittent infusions of β-lactam antibiotics in critically ill adults with sepsis or sep</pubmed_abstract><journal>JAMA</journal><pagination>638-648</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11170459</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.</pubmed_title><pmcid>PMC11170459</pmcid><pubmed_authors>Delaney A</pubmed_authors><pubmed_authors>De Waele JJ</pubmed_authors><pubmed_authors>Dulhunty JM</pubmed_authors><pubmed_authors>Sjovall F</pubmed_authors><pubmed_authors>Cotta MO</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Rajbhandari D</pubmed_authors><pubmed_authors>Di Tanna GL</pubmed_authors><pubmed_authors>Omar S</pubmed_authors><pubmed_authors>Devaux A</pubmed_authors><pubmed_authors>Khan AB</pubmed_authors><pubmed_authors>Novy E</pubmed_authors><pubmed_authors>Lipman J</pubmed_authors><pubmed_authors>Monti G</pubmed_authors><pubmed_authors>Brett SJ</pubmed_authors><pubmed_authors>Hammond NE</pubmed_authors><pubmed_authors>Hasan MS</pubmed_authors><pubmed_authors>Zangrillo A</pubmed_authors><pubmed_authors>Elkady H</pubmed_authors><pubmed_authors>Roger C</pubmed_authors><pubmed_authors>Zaghi I</pubmed_authors><pubmed_authors>Abdul-Aziz MH</pubmed_authors><pubmed_authors>Myburgh J</pubmed_authors><pubmed_authors>Eriksson L</pubmed_authors><pubmed_authors>Roberts JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.</name><description>&lt;h4>Importance&lt;/h4>There is uncertainty about whether prolonged infusions of β-lactam antibiotics improve clinically important outcomes in critically ill adults with sepsis or septic shock.&lt;h4>Objective&lt;/h4>To determine whether prolonged β-lactam antibiotic infusions are associated with a reduced risk of death in critically ill adults with sepsis or septic shock compared with intermittent infusions.&lt;h4>Data sources&lt;/h4>The primary search was conducted with MEDLINE (via PubMed), CINAHL, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov from inception to May 2, 2024.&lt;h4>Study selection&lt;/h4>Randomized clinical trials comparing prolonged (continuous or extended) and intermittent infusions of β-lactam antibiotics in critically ill adults with sepsis or sep</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-06T17:38:07.059Z</modification><creation>2025-04-06T15:07:48.528Z</creation></dates><accession>S-EPMC11170459</accession><cross_references><pubmed>38864162</pubmed><doi>10.1001/jama.2024.9803</doi></cross_references></HashMap>